| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 9,360 | $40 | $355.7K |
| J9271 | Injection, pembrolizumab, 1 mg | 4,000 | $40 | $176.1K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 830 | $40 | $29.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 320 | $90 | $27.2K |
| J0897 | Injection, denosumab, 1 mg | 1,500 | $20 | $27K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $100 | $16.4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,700 | $1 | $13.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $130 | $11.2K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 100 | $90 | $9.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 60 | $130 | $7.8K |